Page 65 - Pharma

"Novel drug delivery system is driving the demand for innovative excipients"

In this interview, Veena Singh, Regional Commercial Manager, Dow Pharma & Food Solutions, Dow India, elaborates on the growth drivers for the excipients market in India

US-based Cancer Genetics acquires BioServe India

The expansion into India will also allow Cancer Genetics to strengthen its capabilities in molecular testing, DNA synthesis, biomarker analysis and next-generation sequencing

Sun Pharma unit recalls cephalexin capsules from US: PTI

Recall triggered by a USFDA notification stating that these products were manufactured with APIs that were not manufactured with GMP

Cipla net profit down by 40% in Q1

The company's total expenses went up by 17% at Rs 2303 crore for the first quarter of FY 14-15

Essel Propack plans expansion with Rs 145-cr investment

The company to spend Rs 70 crore and Rs 75 crore for domestic and overseas operations respectively

Wockhardt's net profit witnesses steep fall in Q1

Sales also down by 27% to Rs 991 crore

Upward revision of drug prices help MNC pharma brands to grow

Centrum Broking report says that MNCs share in the domestic pharma market is expected to go up to 20% in the current fiscal, and further up to 21 per cent in FY16

Fire at Nutraplus' Tarapur factory to affect production

Restoration work of production facilities is expected to take at least three to six months

USFDA reports serious violations at IPCA's Ratlam facility

As of FY2014, the US market has contributed sales of Rs 420 crore (12% of total sales) for IPCA Labs

Emami to bank on emerging markets to push growth

The company plans to liquidate its UK subsidiary

Government working on policy to promote APIs production

A committee has been formed to look into concessions required to build domestic production capabilities

Sanofi joins hand with Emcure Pharmaceuticals for cancer drugs

While Sanofi will continue to own its oncology range, Emcure will market and distribute these brands in India

Lupin inks pact with LG Life Sciences to launch diabetes drug

The Mumbai-based pharma firm will be responsible for marketing and sales of Basugine, a novel insulin analogue indicated for the treatment of type 1 or type 2 diabetes, in India

Pfizer declares lockout at Thane unit after labour unrest

The lockout may not have any impact on its business operations, as the company had made arrangements, including contract manufacturing of products and import arrangements, for the domestic market

Aurobindo Pharma aims $2 bn revenues in FY15

As part of its long term growth strategy, Aurobindo plans to penetrate into the markets, such as Japan, Brazil and other Latin American countries

Pfizer to buy Baxter's marketed vaccines portfolio for $635 mn

As per the deal, the US-based pharma major will also acquire a portion of Baxter's facility in Orth, Austria, where these vaccines are manufactured

Cipla inks pact to market BioQuiddity's products in EU

Cipla will sell BioQuiddity's anaesthetic products in certain European markets

USFDA raises a red flag for Cadila's ANDA application

Cadila clarifies that USFDA made observations on ANDA, and not on any GMP-related issues at its Moraiya facility in Gujarat

Provisions for settlement with US impact Ranbaxy's earnings

Sales from the North American market dipped 11% over a year to Rs 760 crore

Biocon's R&D spend up by 15%

Of the gross R&D spend of Rs 54 crore, its net R&D spend was Rs 31 crore